Wockhardt gets US drug approvalIndian drug firm Wockhardt has received approval from the US health regulator to market its Oxycodone HCl liquid, used for treating chronic pain, in the American market.The company has received final approval from the US Food and Drug Administration (USFDA) to market 5mg/5ml of Oxycodone HCl liquid, Wockhardt Ltd said in a filing to the Bombay Stock Exchange.The product to be launched by Wockhardt soon will be among the few generic versions of this product in the market. Wockhardt chairman and group CEO Habil Khorakiwala said: “We have filed several Abbreviated New Drug Applications (ANDAs) over the last couple of years from our Morton Grove Pharmaceuticals facility in Illinois, especially for liquid products. This is only the first of few others we expect soon.”India in review talks with USIndia's foreign secretary Subrahmanyam Jaishankar held review talks with US officials on issues ranging from ease of doing business to cooperation on terrorism and climate change.US National Security Advisor Susan E. Rice, US Deputy Secretary of State Antony Blinken and US Trade Representative (USTR) Michael Froman were among some of the planned attendees in the meetings held by the senior Indian representative in Washington this week.At his meeting with Rice in the White House, he reviewed the implementation of initiatives taken during the two summits between Prime Minister Narendra Modi and President Barack Obama in the past one year, the Indian Embassy in the US said.Blinken discussed a range of bilateral, regional and global issues of topical relevance during his meeting with Jaishankar.Jaishankar's meeting with Froman covered the ground of India- US economic and commercial engagement.